A program for the prediction of membrane spanning regions in proteins needs reliable data both for its specification and verification. To benchmark the performance of transmembrane prediction programs, it is necessary to use a test set of sequences with experimentally confirmed transmembrane regions. Such test sets differ in the selection of proteins and very often in the annotation of transmembrane segments of identical proteins.
Introduction and motivation
A program for the prediction of membrane spanning regions in proteins needs reliable data both for its specification and verification. To benchmark the performance of transmembrane prediction programs, it is necessary to use a test set of sequences with experimentally confirmed transmembrane regions. Such test sets differ in the selection of proteins and very often in the annotation of transmembrane segments of identical proteins.
This paper describes a test set which unifies, updates and verifies the existing test sets TMHMM (Sonnhammer et al., 1998) , HTP (Rost et al., 1996) , DAS (Cserzo et al., 1997) , CoPreTHi (Promponas et al., 1998) , SOSUI (Hirokawa et al., 1998) , TMPDB (Shimizu and Nakai, 1994) , HMMTOP (Tusnády and Simon, 1998) . Additional references and information were extracted from SWISS-PROT (Bairoch and Apweiler, 2000) and from the literature.
Concept
The test set is stored in a syntax close to the one used by SWISS-PROT. Four additional line types were introduced to ensure that all information relevant for this test set could be stored.
The TS-line (Test Set) lists references to papers and programs where an individual sequence was mentioned to have been used for training or evaluation. The TR line assigns a level of trust to the transmembrane annotation, based on the experimental data available: Finally the PL line type was introduced to store the plain experimental data as explained in the next section.
Below follows an example for a typical entry in the annotation file: The FT (feature table) lines in the annotation file contain the annotation and the source of the experimental evidence for the annotation.
Formalism to store experimental data Three kinds of experiments were accepted as a source for transmembrane annotation:
• C-terminal fusion with indicator proteins; • Antibody binding: it is tested if an antibody binds to known epitopes; • x-ray diffraction to determine a 3D structure.
The PL (predicate language) lines represent experimental data. These are predicates with two arguments:
The description explains modifications made to the original peptide. The vast majority of papers utilised (93%) describe at least one C-terminal fusion. Such a fusion is expressed with the predicate is stated as fusion(indicator,position).
Measurements are expressed as a combination of the measured property and a value. The description of experiments to determine a protein's topology may look like the one below: 
Results
The current release covers cytoplasmic membrane and mitochondrial inner membrane proteins and includes 320 sequences of which 69 have not previously been used for the training or analysis of transmembrane region prediction methods. Information from 214 papers was used to find 33 membrane proteins with known structures, 24 with an in-depth biochemical characterisation and 142 with at least partial biochemical evidence. Annotations assigned the trust level D should not be used for training or testing purposes. This test set has 199 entries assigned to trust levels A-C. This is more than twice the number of reliable entries other test sets.
'Non-redundant' in Table 1 stands for a subset of entries of trust levels A-C, derived from a protein sequence clustering. Entries with the highest trust level and different topologies were selected from each cluster. The clustering procedure is based on pairwise sequence similarities of 'all against all', using the Smith-Waterman algorithm (Smith and Waterman, 1981) . To measure the statistical significance of each Smith-Waterman score, additional searches with 1000 shuffled copies of the query sequence were performed to determine the Z -score (Comet et al., 1999; Pearson, 2000) . Clusters were built using a single linkage algorithm for a Z -score of 10 or higher.
Discussion
The interpretation of individual experiments with indicator proteins (van Geest and Lolkema, 2000) or post-translational modifications is sometimes difficult. Even data derived from crystal structures leaves room for interpretation. No definite rules can hence be given how experimental data should be mapped to transmembrane annotation.
The augmentation with the underlying experimental data provides necessary background information on remaining ambiguities in the transmembrane annotation and therewith facilitates the evaluation of an algorithm's performance. The numeric values of the indicator proteins's activities may also be used to calibrate the prediction methods.
The test set will be further maintained. We are confident that this work will have a positive impact on future algorithms for the determination of transmembrane regions.
